in this issue
World News and Views :: Top of the News
Lonza Completes Arch Deal; Lists on Singapore Stock Exchange
9:51 AM MDT | October 20, 2011 | Kerri Walsh
Lonza has completed its acquisition of Arch Chemicals for $1.4 billion, or $47.20/share. Lonza says it owns more than 90% of Arch’s outstanding shares, and expects to complete the deal through a short-form merger no later than October 21. Upon completion of the merger, Arch will become an indirect, wholly-owned subsidiary of Lonza. The acquisition creates the largest biocides business, and expands Lonza’s non-pharma life science business, says Lonza CEO Stefan Borgas. “After having built the world's leading pharmaceutical contract...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee